Comprehensive genomic analysis in NRG Oncology/RTOG 9802: A Phase III trial of radiation versus radiation plus procarbazine, lomustine (CCNU), and vincristine in high-risk low-grade glioma

Erica H. Bell, Peixin Zhang, Edward G. Shaw, Jan C. Buckner, Geoffrey R. Barger, Dennis E. Bullard, Minesh P. Mehta, Mark R. Gilbert, Paul D. Brown, Keith J. Stelzer, Joseph P. McElroy, Jessica l. Fleming, Cynthia D. Timmers, Aline P. Becker, Andrea L. Salavaggione, Ziyan Liu, Kenneth Aldape, David G. Brachman, Stanley Z. Gertler, Albert D. MurthaChristopher J. Schultz, David Johnson, Nadia N. Laack, Grant K. Hunter, Ian R. Crocker, Minhee Won, Arnab Chakravarti

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Comprehensive genomic analysis in NRG Oncology/RTOG 9802: A Phase III trial of radiation versus radiation plus procarbazine, lomustine (CCNU), and vincristine in high-risk low-grade glioma'. Together they form a unique fingerprint.

Medicine & Life Sciences